Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01093417 · ClinicalTrials.gov registry record · Phase 2
Study of Vitamin D and Effect on Heart Disease and Insulin Resistance
A Phase 2 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT01093417 is a Phase 2 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 45 participants.
The verdict
NCT01093417, a Phase 2 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how Vitamin D affects endothelial function, inflammation, lipids, insulin resistance, vitamin D levels, and parathyroid hormone (PTH).
Interventions
- OTHER Placebo
- DRUG Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01093417
The ClinicalTrials.gov registry entry for NCT01093417 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01093417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01093417 about?
NCT01093417 is a clinical study titled "Study of Vitamin D and Effect on Heart Disease and Insulin Resistance". The purpose of this study is to evaluate how Vitamin D affects endothelial function, inflammation, lipids, insulin resistance, vitamin D levels, and parathyroid hormone (PTH).
What is the current status of trial NCT01093417?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2010-01. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01093417?
The interventions under investigation include: Placebo (OTHER), Vitamin D (DRUG).
Who is sponsoring clinical trial NCT01093417?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.